Hagi, Takaomi
Kurokawa, Yukinori
Kawabata, Ryohei
Omori, Takeshi
Matsuyama, Jin
Fujitani, Kazumasa
Hirao, Motohiro
Akamaru, Yusuke
Takahashi, Tsuyoshi
Yamasaki, Makoto
Satoh, Taroh
Eguchi, Hidetoshi
Doki, Yuichiro
Funding for this research was provided by:
This study was supported in part by the Supporting Center for Clinical Research and Education (SCCRE) and unrestricted research grant from Ono Pharmaceutical.
Article History
Received: 28 December 2019
Revised: 13 May 2020
Accepted: 18 June 2020
First Online: 3 July 2020
Ethics approval and consent to participate
: The study was approved by the institutional review boards of all participating institutions. A full list of all institutional review boards is provided in Supplementary Table. Patients gave written informed consent before enrolment. The institutional review board’s approved informed consent was not required only for patients who were dead or lost to follow-up. This study was performed in accordance with the Declaration of Helsinki.
: No individual personal data are included in this study.
: All data and materials are available in this study.
: Y.K. received lecture fees and grant from Ono Pharmaceutical. M.Y. received grant from Ono Pharmaceutical. T.S. received lecture fees from Ono Pharmaceutical and Bristol-Myers Squibb and department support grant from Ono Pharmaceutical. Y.D. received lecture fees and grant from Ono Pharmaceutical.
: This study was supported in part by the Supporting Center for Clinical Research and Education (SCCRE) and unrestricted research grant from Ono Pharmaceutical.